Education
About Us
Working with TipRanks
Follow Us
Liquidia Technologies (LQDA)
:LQDA
LQDA Analyst Ratings
Strong Buy
9 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LQDA Stock 12 Month Forecast
Average Price Target
$31.50
▲(130.94%Upside)
| Highest Price Target$45.00 | Average Price Target$31.50 | Lowest Price Target$13.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$13.5
Hold
-1.03%
Downside
Reiterated
06/19/25
Liquidia's stock score is primarily constrained by its significant financial challenges, including persistent losses and high leverage. While recent corporate events and strategic advancements offer positive prospects, the company's financial instability and bearish market sentiment weigh heavily on its overall score.
BTIG
$45
Buy
229.91%
Upside
Reiterated
06/16/25
Raymond James
$14.13→$33
Buy
141.94%
Upside
Reiterated
06/13/25
Wells Fargo
$23→$25
Buy
83.28%
Upside
Reiterated
06/12/25
Analysts' Top Healthcare Picks: Liquidia Technologies (LQDA), Cabaletta Bio (CABA)Liquidia Corporation (LQDA): We rate shares Overweight. Second to market stories like LQDA are often overlooked due to competition against an established incumbent, but Yutrepia does not need to dominate the market to see upside to shares.
Scotiabank
$37
Buy
171.26%
Upside
Reiterated
06/11/25
Bank of America Securities
$25→$23
Buy
68.62%
Upside
Reiterated
06/10/25
Needham
$32
Buy
134.60%
Upside
Reiterated
06/10/25
LifeSci Capital
$41
Buy
200.59%
Upside
Reiterated
06/10/25
H.C. Wainwright
$29→$35
Buy
156.60%
Upside
Reiterated
05/29/25
Jefferies
$27→$31
Buy
127.27%
Upside
Reiterated
05/28/25
Oppenheimer
$13
Sell
-4.69%
Downside
Downgraded
05/19/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$13.5
Hold
-1.03%
Downside
Reiterated
06/19/25
Liquidia's stock score is primarily constrained by its significant financial challenges, including persistent losses and high leverage. While recent corporate events and strategic advancements offer positive prospects, the company's financial instability and bearish market sentiment weigh heavily on its overall score.
BTIG
$45
Buy
229.91%
Upside
Reiterated
06/16/25
Raymond James
$14.13→$33
Buy
141.94%
Upside
Reiterated
06/13/25
Wells Fargo
$23→$25
Buy
83.28%
Upside
Reiterated
06/12/25
Analysts' Top Healthcare Picks: Liquidia Technologies (LQDA), Cabaletta Bio (CABA)Liquidia Corporation (LQDA): We rate shares Overweight. Second to market stories like LQDA are often overlooked due to competition against an established incumbent, but Yutrepia does not need to dominate the market to see upside to shares.
Scotiabank
$37
Buy
171.26%
Upside
Reiterated
06/11/25
Bank of America Securities
$25→$23
Buy
68.62%
Upside
Reiterated
06/10/25
Needham
$32
Buy
134.60%
Upside
Reiterated
06/10/25
LifeSci Capital
$41
Buy
200.59%
Upside
Reiterated
06/10/25
H.C. Wainwright
$29→$35
Buy
156.60%
Upside
Reiterated
05/29/25
Jefferies
$27→$31
Buy
127.27%
Upside
Reiterated
05/28/25
Oppenheimer
$13
Sell
-4.69%
Downside
Downgraded
05/19/25
Best Analysts Covering Liquidia Technologies
1 Month
xxx
Success Rate
10/15 ratings generated profit
Average Return
+4.43%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +4.43% per trade.
3 Months
xxx
Success Rate
8/15 ratings generated profit
Average Return
+8.48%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 53.33% of your transactions generating a profit, with an average return of +8.48% per trade.
1 Year
Success Rate
18/23 ratings generated profit
Average Return
+33.74%
reiterated a buy rating 5 days ago
Copying Julian Harrison's trades and holding each position for 1 Year would result in 78.26% of your transactions generating a profit, with an average return of +33.74% per trade.
2 Years
xxx
Success Rate
26/33 ratings generated profit
Average Return
+69.22%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 78.79% of your transactions generating a profit, with an average return of +69.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LQDA Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
6
14
15
39
43
Buy
0
2
2
4
2
Hold
0
0
0
0
0
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
6
16
17
44
46
Each month's total comprises the sum of three months' worth of ratings.
LQDA Financial Forecast
LQDA Stock Forecast FAQ
What is LQDA’s average 12-month price target, according to analysts?
Based on analyst ratings, Liquidia Technologies’s 12-month average price target is 31.50.
What is LQDA’s upside potential, based on the analysts’ average price target?
Liquidia Technologies has 130.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LQDA a Buy, Sell or Hold?
Liquidia Technologies has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 1 sell ratings.
What is Liquidia Technologies’s price target?
The average price target for Liquidia Technologies is 31.50. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $13.00. The average price target represents 130.94% Increase from the current price of $13.64.
The highest analyst price target is $45.00 ,the lowest forecast is $13.00. The average price target represents 130.94% Increase from the current price of $13.64.
What do analysts say about Liquidia Technologies?
Liquidia Technologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of LQDA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.